Current status of antimicrobial therapy for tuberculosis / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 1437-1440, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-955857
ABSTRACT
Multidrug-resistant tuberculosis has a long treatment course and a low sputum-negative conversion rate, which have always been the treatment challenges. New drugs for multidrug-resistant tuberculosis have been constantly explored by scholars worldwide. Multiple antibacterial drugs have been found to have the therapeutic effects on multidrug-resistant tuberculosis. Treatment options that can shorten the duration of tuberculosis are also being explored. Addition of certain antibacterial drugs has been found to shorten the duration of tuberculosis. This paper reviews the effects of antibacterial drugs against tuberculosis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS